Vibhavadi Medical Center Public Co. Ltd. · SET:VIBHA

Vibhavadi Medical Center Public — Q1 2021 Earnings Presentation

26 slides from Vibhavadi Medical Center Public's earnings presentation, Jun 10, 2021

  1. Slide 1: Vibhavadi Medical Center Public Company Limited

    VIBHA VIBHAVADI MEDICAL CENTER PUBLIC COMPANY LIMITED 10 June 2021

  2. Slide 2: Disclaimers

    DISCLAIMERS FR  The information contained in this presentation is for information purposes only.  This presentation contains forward looking statements which reflect Management’s current views and estimates. The forward-looking statements involve certain risks and uncertainties that could cause ac

  3. Slide 3: Topics

    TOPICs 1 GENERAL INFORMATION 2 FINANCIAL PERFORMANCE 3 FINANCIAL PERFORMANCE 4 OPERATIONAL STATISTICS 3

  4. Slide 4: Company history and milestones

    FR Registered with SET Establishment of Princeton - Started Trading Park Suites March, 1992 - Invest in non-core businesses 1986 2003 2011 1992 2009 Joint Venture to establish Acquire CMR group hospitals Establishment of the Vibharam Group Hospitals - Largest Market-share of company - Targeting Gove

  5. Slide 5: Hospital Locations

    Hospital Locations FR Vibhavadi Hospital Vibharam Hospital Phaetpanya Hospital Seriruk Hospital Laemchabang Hospital Pakkred Hospital Chaiprakarn Hospital Amata Nakorn Hospital Samutsakorn Hospital Mahaesak Hospital Bangpo Hospital Chiangmai Ram Hospital Lanna Hospital Hariphunchai Memmorial Hospita

  6. Slide 6: Group structure and shareholdings

    >» N + Vibhavadi HOSPITAL Tommmui2smed Tsowenuraswerauno Ramkhamhaeng Hospital + Vibhavadi HOSPITAL fomaunasmed J 99.99% 1586 Princeton 33.73% _| Vibharam Park Suites 83.55% Hospital 38.18% <4 Serirak Ls| erccision | | Chiangmai Ram Tete ae 100 00% sera Medical Business: ie lospital = 70.00% Hospita

  7. Slide 7: Topics

    TOPICs 1 GENERAL INFORMATION 2 FINANCIAL HIGHLIGHTS 3 FINANCIAL PERFORMANCE 4 OPERATIONAL STATISTICS 7

  8. Slide 8: Financial Highlights

    FINANCIAL HIGHLIGHTS FR Operational Recap and Financial Summary (YoY) 1.6% ▼ 1,706 1,679 ▲ 19% ▲ 370 440 42% 135 192 Total Revenues EBITDA Net Income* Q1 Y2020 Q1 Y2021 Q1 Y2021 ▲ Gain on sale of investment, 17.7MB ▲ Gain on revaluation of investment, 73MB ▼ 2nd wave of COVID-19 outbreak 8 *Net inco

  9. Slide 9: Total Revenues

    TOTAL REVENUES FR Trend Breakdown by Source (YoY) 1.6% ▼ 1st wave of CMH CMH 1,706 COVID-19 25% 22% 1,725 1,679 VIBHA VIBHA outbreak 1,608 Q1 Y2020 45% Q1 Y2021 45% 1,299 1,706 MB LANNA 1,679 MB LANNA 21% 19% PPS PPS TPY 1% TPY 1% 4% BDC HARI BDC HARI 5% 1% 4% 2% 5% First outbreak started from MARCH

  10. Slide 10: Share Profit from Associates

    SHARE PROFIT FROM ASSOCIATES FR YoY Change Q1 Y2021 Breakdown by Source 260 Ticker Q1 Y2020 Q1 Y2021 YoY VBR 30.31 0.67 ▼ 98% PAWOR Q1 Y2020 26% TBD -3.73 -9.42 ▼ 353% 103% Q1 Y2021 TBD ▼ TOTAL 2019 VBR -52% TOTAL2020 4% BANGPO 0.88 0.78 ▼ 11% 30 (1) KHELANG KHELANG 2.02 2.52 ▲ 25% Net Profit 14% BA

  11. Slide 11: Topics

    TOPICs 2 FINANCIAL HIGHLIGHTS 3 FINANCIAL PERFORMANCE 4 OPERATIONAL STATISTICS 11

  12. Slide 12: Financial Performance

    FINANCIAL PERFORMANCE FR Consolidated Financial 1,706 1,608 1,725 1,679 Period Q2 Q3 Q4 Q1 (QoQ) Y2020 Y2020 Y2020 Y2021 1,299 Total ▼24% ▲ 24% ▲ 7% ▼ 3% Revenue 370 371 404 440 202 233 197 53 338 EBITDA ▼ 45% ▲ 83% ▲ 9% ▲ 9% (65) Q1 Y2020 Q2 Y2020 Q3 Y2020 Q4 Y2020 Q1 Y2021 Net Profit ▼ 133% ▲ 182%

  13. Slide 13: Total Revenues

    TOTAL REVENUES FR Breakdown by Source Ticker YoY change 1.6% ▼ VIBHA ▼ 5.7% CMH CMH 25% 22% CMH ▼ 18.4% Q1 Y2020 VIBHA Q1 Y2021 VIBHA LANNA ▲ 4.2% 1,706 MB 45% 1,679 MB 45% LANNA TPY ▼ 19.4% LANNA 21% 19% HARI ▲ 2.2% BDC ▲ 51% PPS TPY PPS ▲ 94.5% PPS TPY BDC HARI 1% BDC HARI 4% 1% 5% 1% 4% 2% 5% Q1

  14. Slide 14: Revenue from Medical Treatment

    REVENUE FROM MEDICAL TREATMENT FR Breakdown by Department 8% (YoY) OPD IPD SS SS ▼ SS 16% 19% IPD Revenue ▼ 3.5% ▼ 20.3% ▲ 5.5% Q1 Y2020 IPD Q1 Y2021 40% 1,608 MB 45% 1,473 MB Number of ▼ 14.6% ▼ 23.8% ▼ 9.1% OPD Patient OPD 39% 41% Revenue ▲ 13.1% ▲ 4.7% ▲ 16.1% per visit Revenue from medical treat

  15. Slide 15: Revenue from Fee-for-Service

    REVENUE FROM FEE-FOR-SERVICE FR Breakdown by Payer 8% YoY Change OTHERS OTHERS 4% ▼ 5% PRIVATE Self-pay ▼ 6.5% PRIVATE INSURANCE INSURANCE 32% Q1 Y2020 29% Q1 Y2021 SELF-PAY SELF-PAY Corporate Contract ▼ 28.6% 1,608 MB 1,473 MB 61% 57% Private Insurance ▼ 21.6% CORPORATE CORPORATE CONTRACT CONTRACT

  16. Slide 16: Revenue from SSO

    REVENUE FROM SSO FR Breakdown by Type YoY Change ▲ 5.53% Revenue ▲ 5.5% DRG>2 DRG>2 Number of Patient ▼ 9.1% 28% BASIC 30% BASIC 39% 37% Revenue per head ▲ 16.1% Q1 Y2020 Q1 Y2021 264 MB 278 MB RISK RISK ADJUSTED ADJUSTED 22% 21% EQUIPMENT EQUIPMENT 6% OTHERS 6% OTHERS 4% CHECK UP CHECK UP 5% 1% 1%

  17. Slide 17: Financial Performance: Associated Company Profit

    FINANCIAL PERFORMANCE FR Associated Company Profit 128 Ticker Q1 Y2020 Q1 Y2021 YoY VBR 30.31 0.67 ▼ 98% 30 TBD -3.73 -9.42 ▼ 353% Q1 Y2020 Q2 Y2020 Q3 Y2020 Q4 Y2020 Q1 Y2021 (1) BANGPO 0.88 0.78 ▼ 11% (105) KLELANG 2.02 2.52 ▲ 25% (115) TBD KHELANG VBR BANGPO PAWOR Share Profit PAWOR 0.61 4.69 ▲ 6

  18. Slide 18: Financial Ratio

    FINANCIAL RATIO FR YEAR 2016 2017 2018 2019 2020 31/05/2021 ROA (%) 9.37 9.45 7.91 7.96 4.24 4.26 ROE (%) 11.23 12.58 10.25 10.86 5.64 6.03 Net Profit (%) 11.47 17.00 13.18 14.45 8.50 13.90 P/E 54.02 40.12 31.40 31.50 67.71 62.53 P/BV 5.95 4.96 3.70 3.12 2.60 3.50 Book Value per 0.51 0.52 0.54 0.58

  19. Slide 19: Group Significant Figures

    GROUP SIGNIFICANT FIGURES FR Capital Structure Debt-to-Equity Ratio 1.01 19% Equity 0.99 LT Loan 12% 51% 0.97 0.97 0.97 Other 18% ST Loan Q1 Y2020 Q2 Y2020 Q3 Y2020 Q4 Y2020 Q1 Y2021 Earning Per Share Interest Coverage Ratio EPS Accumulated 8.42 8.80 0.0304 7.43 6.73 0.0228 0.0129 4.05 0.0092 0.0086

  20. Slide 20: Topics

    TOPICs 2 FINANCIAL HIGHLIGHTS 3 FINANCIAL PERFORMANCE 4 OPERATIONAL STATISTICS 20

  21. Slide 21: COVID-19 Testings

    COVID-19 TESTINGS FR Volume Trend from 1st to 3rd Waves 3rd wave 7,260 6,726 No Drive-thru COVID-19 Test Service 1st 2nd wave wave 1,476 1,396 1,140 283 198 68 M3 M4 M5 M6 M7 M8 M9 M10 M11 M12 M1 M2 M3 M4 M5 Y2020 Y2020 Y2020 Y2020 Y2020 Y2020 Y2020 Y2020 Y2020 Y2020 Y2021 Y2021 Y2021 Y2021 Y2021 CO

  22. Slide 22: Number of Patients

    NUMBER OF PATIENTS FR General Medical Treatment 223,420 13,615 OPD IPD Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Y2019 Y2020 Y2021 Y2019 Y2020 Y2021 SSO Medical Treatment 6,233 207,942 OPD IPD Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Y2019 Y2020 Y2021 Y2019 Y2020 Y2021 22

  23. Slide 23: Operational Statistics

    OPERATIONAL STATISTICS FR Number of Registered SSO Patients Quota 990,000 698,179 702,848 Quota 695,000 444,312 455,415 Quota 295,000 253,867 247,433 CMR VBR TOTAL Q1 Y2020 Q1 Y2021 23

  24. Slide 24: Strategies for upcoming quarters

    FR Strategies for upcoming quarters Adapting to COVID-19 We provide green, yellow and red services COVID-19 Drive Thru and converting Converting Hotels to ASQ and Hospitel Low-occupied hospitals for COVID-19 patients Add a footer 24

  25. Slide 25: Upcoming Trends for 2021

    UPCOMING TRENDS FOR 2021 FR For Q2 2021, we expect  Number of fee-for-service OPD and IPD patients to slowly recover from 2020, however, it would still not be back to the number prior to COVID-19 outbreak.  However, from Q2 onwards, if COVID-19 outbreak still continues, revenue from COVID-19 tests

  26. Slide 26: Q & A

    Q&A Vibhavadi Hospital 02-561-1111 info@vibhavadi.com www.vibhavadi.com www.facebook.com/hospital4 @vibhavadihospital

Vibhavadi Medical Center Public Company — Q1 2021 Earnings Presentation on 6ix